Evidence map›Paper›PMID 33239156›Full record

SynthesisUltrasound in medicine & biology2021

Contrast-Enhanced Ultrasound for Monitoring Non-surgical Treatments of Uterine Fibroids: A Systematic Review.

Mehnoosh Torkzaban, Priscilla Machado, Ipshita Gupta, Yang Hai, Flemming Forsberg

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Ultrasound in medicine & biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Mehnoosh TorkzabanDepartment of Radiology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Priscilla MachadoDepartment of Radiology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Ipshita GuptaSchool of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore.
Yang HaiDepartment of Radiology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Flemming ForsbergDepartment of Radiology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Electronic address: flemming.forsberg@jefferson.edu.
Thomas Jefferson University · USNanyang Technological University · SG

Funding

Evaluating uterine fibroids with contrast-enhanced ultrasound imaging (CEUS) and superb microvascular imaging (SMI) pre and post uterine artery embolization (UAE)R03EB028464 · NIBIB · THOMAS JEFFERSON UNIVERSITY · PI GONSALVES, CARIN F · 2019 to 2020
$156k
NIBIB NIH HHS R03 EB028464
6 · The paper itself

Abstract

Non-surgical treatment options for uterine fibroids are uterine artery embolization (UAE), high-intensity focused ultrasound ablation (HIFUA), and percutaneous microwave ablation (PMWA). Magnetic resonance imaging (MRI) is the reference standard imaging method before and after these procedures. Contrast-enhanced ultrasound (CEUS) has been studied as an alternative to MRI for evaluating the fibroids' characteristics and responses to non-surgical treatments. PubMed, Ovid MEDLINE and Scopus databases were searched for literature published from January 2000 through June 7, 2020, that investigated the application of CEUS as an adjunct to monitor UAE, HIFUA or PMWA in human uterine fibroid treatments. Two independent reviewers analyzed 128 publications, out of which 17 were included. Based on this systematic review, CEUS provides detailed data about fibroid volume and vascularization prior, during and post UAE, and it helps determine the endpoint of the procedure. HIFUA with intra-procedural CEUS has faster volume shrinkage over a shorter time period with less needed energy and provides early detection of residual tissue after HIFUA. CEUS and contrast-enhanced MRI have sufficient agreement to be used interchangeably in the clinic to evaluate the therapeutic effect of PMWA and HIFUA on fibroids.

Indexed as

Contrast MediaFemaleHumansLeiomyomaUltrasonographyUterine NeoplasmsContrast MediaContrast-enhanced ultrasoundHigh-intensity focused ultrasound ablationPercutaneous microwave ablationUterine artery embolizationUterine fibroid

Identifiers

PMID33239156
PMCPMC7703678
OpenAlexW3094082442

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.